Litcius/Paper detail

Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): An international multicenter study

A. Gafita, I. Rauscher, M.E. Weber, B. Hadaschik, H. Wang, W.R. Armstrong, R. Tauber, T.R. Grogan, J. Czernin, M.B. Rettig, K. Herrmann, Jérémie Calais, W. Weber, M.R. Benz, W.P.W Fendler, M. Eiber

2022European Urology16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstate cancerMulticenter studyCastrationOncologyCancerProstateRadiologyInternal medicineRandomized controlled trialHormoneProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsCancer, Lipids, and Metabolism
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): An international multicenter study | Litcius